iifl-logo
  • testing
  • |

iifl-logo

Zydus Lifesciences Ltd Annually Results

981.8
(0.84%)
Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

22,573.8

19,021.5

16,877.8

14,827.6

14,125

Excise Duty

0

0

0

0

0

Net Sales

22,573.8

19,021.5

16,877.8

14,827.6

14,125

Other Operating Income

667.7

525.9

359.6

282.3

278.5

Other Income

269.5

307.1

186.6

2,583.1

45.6

Total Income

23,511

19,854.5

17,424

17,693

14,449.1

Total Expenditure

16,402.6

14,177.3

13,986.3

11,769.2

11,289.5

PBIDT

7,108.4

5,677.2

3,437.7

5,923.8

3,159.6

Interest

165.9

81.2

129.9

127

158.8

PBDT

6,942.5

5,596

3,307.8

5,796.8

3,000.8

Depreciation

915.8

764.1

722.7

713

669.6

Minority Interest Before NP

0

0

0

0

0

Tax

2,049.3

1,492.6

690.4

441.5

453

Deferred Tax

-637.4

-515.1

-102.6

70.2

-259.4

Reported Profit After Tax

4,614.8

3,854.4

1,997.3

4,572.1

2,137.6

Minority Interest After NP

147.1

113.3

131.6

131

51.4

Net Profit after Minority Interest

4,525.5

3,859.5

1,960.3

4,487.3

2,133.6

Extra-ordinary Items

-144.93

4.39

-447.72

2,338.08

-234.37

Adjusted Profit After Extra-ordinary item

4,670.43

3,855.11

2,408.02

2,149.22

2,367.97

EPS (Unit Curr.)

44.97

38.14

19.3

43.84

20.85

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,100

300

600

250

350

Equity

100.6

100.6

101.2

102.4

102.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.48

29.84

20.36

39.95

22.36

PBDTM(%)

30.75

29.41

19.59

39.09

21.24

PATM(%)

20.44

20.26

11.83

30.83

15.13

Zydus Lifesci.: Related NEWS

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.